Monash University's SPHERE Centre of Research Excellence Director Professor Danielle Mazza AM has welcomed the Australian Government's announcement of increased Medicare support for Long-Acting Reversible Contraceptive (LARC).
From 1 November 2025, the Medicare rebate for four existing Medicare items covering insertion and removal of LARCs is being increased significantly.
Medicare item numbers are also being added to cover insertion and removal of LARCs by nurse practitioners.
Additionally if the insertion or removal and associated consultation is bulk billed there will be a 40 per cent loading added to the rebate. This bulk billing incentive is being provided to try and remove current, sometimes large, out of pocket costs incurred by women who choose to use LARC for contraception.
Professor Danielle Mazza AM, Head of General Practice at Monash University, Chief Investigator and Director of the SPHERE Centre of Research Excellence in Women's Sexual and Reproductive Health in Primary Care and Australian National and Victorian Women's Health Advisory Council member
